Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Semin Arthritis Rheum. 2015 Jun 19;45(3):309–314. doi: 10.1016/j.semarthrit.2015.06.011

Figure 2.

Figure 2

Kaplan-Meier survival analyses for subjects in the five serum autoantibody groups. The Combined group consisted of patients with RNA pol, U1RNP and negative autoantibodies who had similar survival. The Other group consisted of patients with non-specific antinuclear or overlapping antibodies. One hundred thirty subjects were censored. The median (range) follow-up time was 2.1 years (0.01-6.8). AC=anticentromere, NUC= nucleolar ANA, Scl-70=anti-topoisomerase I, Combined= RNA polymerase III/U1RNP/Negative.